Information Provided By:
Fly News Breaks for April 26, 2017
HSTM
Apr 26, 2017 | 08:24 EDT
Baird analyst Matthew Gillmor raised his price target on HealthStream to $35 from $31 following Q1 results. The analyst believes growth for the company is just beginning to inflect higher as ICD headwinds fade and help to showcase stronger underlying trends. He also said the current valuation is still at or below historical trough valuation levels. Gillmor reiterated his Outperform rating on HealthStream shares.
News For HSTM From the Last 2 Days
HSTM
HSTM
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.